Nicolas Mottet

Tranexamic Acid for the Prevention of Blood Loss after Cesarean Delivery

Marie Victoire Sénat, Maëla Le Lous, Norbert Winer et al. · New England Journal of Medicine · 2021 · 272 citations · Full text

Medicine, Obstetrics, Pharmacotherapy +16

Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses

Christian Pfister, Gwénaëlle Gravis, Aude Fléchon et al. · European Urology · 2020 · 247 citations · Full text

Medicine, Oncology, Urology +14

Maternal outcomes and risk factors for COVID-19 severity among pregnant women

Manon Vouga, Guillaume Favre, Óscar Martínez Pérez et al. · Scientific Reports · 2021 · 147 citations · Full text

Public Health, Maternal Health, Obstetrics +17

Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study

Christian Pfister, Gwénaëlle Gravis, Aude Fléchon et al. · The Lancet Oncology · 2023 · 96 citations

Medicine, Oncology, Pharmacology +14

Maternal and perinatal outcomes following pre-Delta, Delta, and Omicron SARS-CoV-2 variants infection among unvaccinated pregnant women in France and Switzerland: a prospective cohort study using the COVI-PREG registry

Guillaume Favre, Émeline Maisonneuve, Léo Pomar et al. · The Lancet Regional Health - Europe · 2023 · 66 citations · Full text

Public Health, Infectious Diseases, Maternal Health +17